Spyros Skoulakis

1.0k citations
10 papers · 770 indexed · h-index 8
Topics
Acute Myeloid Leukemia Research (4 papers)Genomic variations and chromosomal abnormalities (3 papers)Chromosomal and Genetic Variations (2 papers)
Partner nations
United KingdomGermany

In The Last Decade

Spyros Skoulakis

10 papers receiving 758 citations

Peers

Spyros Skoulakis
Comparison fields: 5 of 63
  • Molecular Biology 465
  • Hematology 300
  • Cancer Research 272
  • Genetics 149
  • Genetics 136
Replace Nicola Foot with:
Nicola Foot United Kingdom
Chimene Kesserwan United States
Paolo Gorello Italy
Tim Ripperger Germany
Marie‐Josée Le Bris France
Munetake Shimabe Japan
Nicoletta Coccaro Italy
Françoise Brizard France
Afua A. Mensah Switzerland
J. W. G. Janssen Germany
Spyros Skoulakis relative to Nicola Foot United Kingdom Nicola Foot's profile →
Citations per field
00.5×1.5×2.4×
Nicola Foot · 1×
Citations per year

Countries citing papers authored by Spyros Skoulakis

Since Specialization
Citations

This map shows the geographic impact of Spyros Skoulakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spyros Skoulakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spyros Skoulakis more than expected).

Fields of papers citing papers by Spyros Skoulakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spyros Skoulakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spyros Skoulakis. The network helps show where Spyros Skoulakis may publish in the future.

Co-authorship network of co-authors of Spyros Skoulakis

This figure shows the co-authorship network connecting the top 25 collaborators of Spyros Skoulakis. A scholar is included among the top collaborators of Spyros Skoulakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spyros Skoulakis. Spyros Skoulakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 169
2 12
3 61
4 116
5 205
6 178
7 12
8 1
9 6
10 10

About Spyros Skoulakis

Spyros Skoulakis is a scholar working on Hematology, Cancer Research and Dermatology, having authored 10 papers that have together received 770 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Genomic variations and chromosomal abnormalities (3 papers) and Chromosomal and Genetic Variations (2 papers). The work is most often cited by research in Hematology (300 citations), Cancer Research (272 citations) and Genetics (136 citations). Spyros Skoulakis has collaborated with scholars based in United Kingdom and Germany. Frequent co-authors include Bryan D. Young, Silvana Debernardi, Tracy Chaplin, Manoj Raghavan, Debra M. Lillington, Tim Lister, Nicola Foot, Gael Molloy, Amanda Dixon‐McIver and Lan‐Lan Smith. Their work appears in journals such as Blood, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026